SHARPIN and glioblastoma: Considering that the levels of SHARPIN and STING proteins were the highest regulated with the delphinidin treatments at concentrations of 120 μM for 24 h, we performed a bioinformatic analysis using the GlioVis platform to evaluate the survival of patients, concerning the expression levels of both markers in glioblastoma and their possible correlation with MGMT expression.